TOTAL: Teaching Obesity Treatment Options to Adult Learners Intervention Via VA Video Connect

Sponsor
University of Wisconsin, Madison (Other)
Overall Status
Active, not recruiting
CT.gov ID
NCT04878289
Collaborator
(none)
9
1
1
23.5
0.4

Study Details

Study Description

Brief Summary

The goal of this study is to assess the feasibility and acceptability of Teaching Obesity Treatment Options to Adult Learners (TOTAL intervention), which includes an educational video about obesity treatment options within VA in conjunction with three telemedicine motivational sessions to increase obesity treatment initiation. 10 participants will be recruited from the Madison VA Medical Center. Participation involves 3.5 hours of total time with study follow up to 18 months.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: TOTAL with Motivational Telemedicine Sessions
N/A

Detailed Description

Obesity is the second leading cause of death in the U.S. The treatment of obesity and its related comorbidities, including cardiovascular disease and diabetes, exceeds $150 billion annually. "Morbidly" or "severely" obese patients, defined by a body mass index (BMI) of 35 kg/m² or greater, are especially high risk for serious complications due to the metabolic and physiologic derangements that occur with severe obesity. Within the Veterans Health Administration (VA) system, nearly 600,000 patients are severely obese. These Veterans exert significant costs on the VA system, experience poorer quality of life, and have shortened lifespans. Bariatric surgery is the most effective treatment for severe obesity for weight loss, comorbidity resolution, and quality of life. Bariatric surgery is supported as a treatment option by many national societies, including those representing primary care and endocrinology. However, less than 1% of Veterans who qualify for bariatric surgery undergo it. The investigator's previous research indicates that two important barriers to obesity treatment participation are poor Veteran knowledge about the risks of obesity and obesity treatment options, and lack of Veteran motivation.

The goal of this study is to assess the feasibility and acceptability of Teaching Obesity Treatment Options to Adult Learners (TOTAL intervention) among Veterans with overweight/obesity who are not participating in MOVE! program (a Weight Management Program, supported by VA's National Center for Health Promotion and Disease Prevention (NCP). The primary outcomes will be recruitment and retention rates and acceptability of TOTAL. The secondary outcomes include MOVE! program initiation sustained MOVE! participation, obesity medication receipt, bariatric surgery referral, and weight loss 18 months post-intervention.

The investigators propose to pilot test the TOTAL intervention for up to 10 Veterans with overweight/obesity who are not currently participating in MOVE!. Once participants are consented and baseline data are obtained, participants will view the TOTAL video and participate in three one-on-one, 30-minute motivational sessions via VVC at 1-week, 6-months, and 12-months. All VVC sessions will be audio recorded. This timing was selected so Veterans would have regular interactions with the interventionist within one year of initiating the intervention. Each motivational session will be tailored to where Veterans are in the treatment initiation process. Further, the investigators will conduct 15-minute participant interviews after each motivational session to assess how the TOTAL educational video and the motivational sessions are received by Veterans using VVC. These interviews will not be audio-recorded. Lastly, participants will complete a brief post-assessment at the 18-month visit to obtain information about their obesity initiation/treatment as well as their final weight.

Study Design

Study Type:
Interventional
Actual Enrollment :
9 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
A Non-randomized Pilot Study of the Teaching Obesity Treatment Options to Adult Learners (TOTAL) Intervention Via VA Video Connect (VVC)
Actual Study Start Date :
Apr 15, 2021
Anticipated Primary Completion Date :
Apr 1, 2023
Anticipated Study Completion Date :
Apr 1, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: TOTAL Intervention

TOTAL video and participate in three one-on-one, 30-minute motivational sessions via VVC at 1-week, 6-months, and 12-months

Behavioral: TOTAL with Motivational Telemedicine Sessions
Teaching Obesity Treatment Options to Adult Learners Educational Video with 3, 30 minute motivational sessions at 1 week, 6 months, and 12 months after viewing video

Outcome Measures

Primary Outcome Measures

  1. Recruitment: Number of Participants Consented Compared to Number of Recruitment Letters Sent [up to 18 months]

    The ratio of consented participants to number of recruitment letters sent will measure the level of recruitment in this pilot study.

  2. Retention: Number of Participants Who Completed the Intervention Compared to Number of Participants Consented [up to 18 months]

    The ratio of participants who watched the video and completed all three telemedicine sessions to the number of participants consented will measure the level of retention in this pilot study.

  3. Acceptability [1 week]

    Participants will be asked about their perceptions of watching the video and completing the motivational sessions via VVC at each session (1 week, 6 months, 12 months). Participant perceptions will be summarized qualitatively.

  4. Acceptability [6 months]

    Participants will be asked about their perceptions of watching the video and completing the motivational sessions via VVC at each session (1 week, 6 months, 12 months). Participant perceptions will be summarized qualitatively.

  5. Acceptability [12 months]

    Participants will be asked about their perceptions of watching the video and completing the motivational sessions via VVC at each session (1 week, 6 months, 12 months). Participant perceptions will be summarized qualitatively.

Secondary Outcome Measures

  1. Number of Participants who initiated Obesity Treatment [up to 18 months]

    Attendance at a MOVE! visit (chart review); participation in another behavioral weight loss program (self-report), data collected at baseline, 1 week, 6 months, 12 months, 18 months

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 70 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Veteran

  • BMI of 30 or greater, or

  • BMI of 27 or greater with an obesity-related comorbidity

  • Primary Care Physician visit within the past 12 months

Exclusion Criteria:
  • Participation in the MOVE! program within the past 12 months

  • Receipt of a weight-loss medication within the past 12 months

  • Bariatric surgery referral within the past 12 months

  • Has had bariatric surgery

  • Previous stomach or small intestine surgery (at discretion of the PI)

  • Severe medical condition that would preclude meaningful participation in the study

  • Pregnancy or intended pregnancy during the study period

  • Current breast feeding

  • Cancer not in remission

  • Lack of regular access to a telephone

  • Lack of regular access to internet-connected device with a microphone such as a computer/laptop/tablet/smart phone

  • Non-English speaking

  • Hearing impairment

Contacts and Locations

Locations

Site City State Country Postal Code
1 William S. Middleton VA Hospital Madison Wisconsin United States 53705

Sponsors and Collaborators

  • University of Wisconsin, Madison

Investigators

  • Principal Investigator: Luke Funk, MD, MPH, FACS, William S. Middleton VA

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
University of Wisconsin, Madison
ClinicalTrials.gov Identifier:
NCT04878289
Other Study ID Numbers:
  • 2020-1043
  • A539712
  • SMPH/SURGERY/MIS
  • Protocol Version 12/21/2020
First Posted:
May 7, 2021
Last Update Posted:
Dec 7, 2021
Last Verified:
Dec 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by University of Wisconsin, Madison
Additional relevant MeSH terms:

Study Results

No Results Posted as of Dec 7, 2021